Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530289) titled 'A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018)' on April 7.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Merck Sharp & Dohme LLC
Condition:
Healthy
Intervention:
Drug: Atorvastatin
Drug: Metformin
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: May 1, 2026
Target Sample Size: 12
To know more, visit https://clinicaltrials.gov/study/NCT07530289
Disclaimer: Curated by HT Syndication....